Herbert Wiser, MD
Urology · de Pere, WINPI 1053573147
Payments from drug & device makers
Across 54 payments — averaging $27.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$202
- Teleflex LLC$201
- Olympus America Inc.$157
- EDAP Technomed Inc$144
- Progenics Pharmaceuticals, Inc.$115
- Sumitomo Pharma America, Inc.$113
- plus $540 from 13 others
What the payments were for
- Food & beverage$1,472100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 3 | $202 |
| Teleflex LLC | 2 | $201 |
| Olympus America Inc. | 12 | $157 |
| EDAP Technomed Inc | 6 | $144 |
| Progenics Pharmaceuticals, Inc. | 1 | $115 |
| Sumitomo Pharma America, Inc. | 6 | $113 |
| Intuitive Surgical | 1 | $92 |
| AbbVie | 5 | $82 |
| Astellas Pharma US Inc | 3 | $59 |
| Endo Pharmaceuticals Inc. | 3 | $56 |
| Urogen Pharma, Inc. | 2 | $55 |
| Merck | 2 | $43 |
| Laborie Medical Technologies Corp. | 2 | $35 |
| Pfizer | 1 | $23 |
| Coloplast | 1 | $21 |
| Medtronic | 1 | $21 |
| Procept Biorobotics Corporation | 1 | $20 |
| Bayer | 1 | $16 |
| Koelis Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,472 in reported general payments places this provider in the 60th percentile of 215 urology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxybutynin Chloride | 92 | $976 |
| Tamsulosin Hcl | 63 | $717 |
| Cephalexin | 75 | $714 |
| Finasteride | 57 | $461 |
| Doxycycline Monohydrate | 24 | $445 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 90 | $326 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 45 | $163 |
| Ciprofloxacin Hcl | 15 | $57 |
| Levofloxacin | 24 | $38 |
Paid to pharmacies, not to this prescriber.
Other urology in de Pere
- Hamayun Miande Pere$6K
- Sean McAdamsde Pere$5K
- Marvin Vaneveryla Crosse$325K
- Matthew GrimesMadison$278K
- Margaret KnoedlerMadison$182K
- Edwin AbelMadison$179K
- Dan GralnekMadison$142K
- Amy GuiseMilwaukee$115K
- Eric LawatschNeenah$114K
- Christopher ManakasMadison$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.